Principal operating subsidiaries include Premier Packaging Corporation (folding cartons and paperboard packaging), American Pacific Financial (commercial banking, investment banking, and asset management), and Sentinel Brokers Company, Inc. (FINRA-registered broker-dealer specializing in institutional bond brokerage and equity market making). The portfolio approach allows DSS to diversify revenue streams across packaging, healthcare innovation, financial services, and alternative assets.
Cyborg Score Rationale
In 2025, DSS revenue was $20.76 million, an increase of 8.69% compared to the previous year, but losses were -$23.93 million. The company operates across fragmented business lines with modest revenue but substantial losses, creating uncertainty about profitability and capital efficiency.
Top Insights
In February 2026, DSS closed a $1.0 million underwritten public offering before deducting underwriting fees and other offering expenses.
DSS announced the sale of its Celios air purification technology to Impact BioMedical in an all-equity transaction valued at $1.15 million as part of portfolio optimization strategy to focus on core growth areas.
Company operates as a holding/acquisition platform targeting high-growth sectors (packaging, biotech, fintech) with the stated goal of creating subsidiary value and returning it to shareholders through spin-offs.
Trading on NYSE American with historical compliance challenges; stock price has remained depressed relative to listing standards.
Named Competitors
Packaging Products — Global packaging solutions and food service products
Consumer Packaging — Protective packaging and food packaging solutions